Scandinavian Journal of Rheumatology 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Sick leave and disability pension following delivery in women with systemic lupus erythematosus
CONCLUSION: SLE mothers more often had work loss in the prenatal year to 3 years postpartum compared to non-SLE mothers. Lower education and sick leave in the year of delivery were associated with a higher odds of work loss in the first year postpartum in SLE.PMID:38607692 | DOI:10.1080/03009742.2024.2321057 (Source: Scandinavian Journal of Rheumatology)
Source: Scandinavian Journal of Rheumatology - April 12, 2024 Category: Rheumatology Authors: D Grannas J F Simard E Svenungsson E V Arkema Sam Gernaat Source Type: research
Sick leave and disability pension following delivery in women with systemic lupus erythematosus
CONCLUSION: SLE mothers more often had work loss in the prenatal year to 3 years postpartum compared to non-SLE mothers. Lower education and sick leave in the year of delivery were associated with a higher odds of work loss in the first year postpartum in SLE.PMID:38607692 | DOI:10.1080/03009742.2024.2321057 (Source: Scandinavian Journal of Rheumatology)
Source: Scandinavian Journal of Rheumatology - April 12, 2024 Category: Rheumatology Authors: D Grannas J F Simard E Svenungsson E V Arkema Sam Gernaat Source Type: research
Sick leave and disability pension following delivery in women with systemic lupus erythematosus
CONCLUSION: SLE mothers more often had work loss in the prenatal year to 3 years postpartum compared to non-SLE mothers. Lower education and sick leave in the year of delivery were associated with a higher odds of work loss in the first year postpartum in SLE.PMID:38607692 | DOI:10.1080/03009742.2024.2321057 (Source: Scandinavian Journal of Rheumatology)
Source: Scandinavian Journal of Rheumatology - April 12, 2024 Category: Rheumatology Authors: D Grannas J F Simard E Svenungsson E V Arkema Sam Gernaat Source Type: research
Van Neck-Odelberg disease in an elderly patient
Scand J Rheumatol. 2024 Apr 2:1-2. doi: 10.1080/03009742.2024.2330248. Online ahead of print.NO ABSTRACTPMID:38563192 | DOI:10.1080/03009742.2024.2330248 (Source: Scandinavian Journal of Rheumatology)
Source: Scandinavian Journal of Rheumatology - April 2, 2024 Category: Rheumatology Authors: X Wang W Feng Source Type: research
Comparing the safety and efficacy of nintedanib starting dose in patients with connective tissue disease-associated interstitial lung diseases
CONCLUSION: There was no evidence for a difference between the two groups in terms of discontinuation rates, efficacy, and safety. To provide further evidence, future studies using more precise dose-escalation protocols are warranted.PMID:38563202 | DOI:10.1080/03009742.2024.2327159 (Source: Scandinavian Journal of Rheumatology)
Source: Scandinavian Journal of Rheumatology - April 2, 2024 Category: Rheumatology Authors: M Ayano K Tsubouchi K Suzuki Y Kimoto Y Arinobu K Akashi T Horiuchi I Okamoto H Niiro Source Type: research
Van Neck-Odelberg disease in an elderly patient
Scand J Rheumatol. 2024 Apr 2:1-2. doi: 10.1080/03009742.2024.2330248. Online ahead of print.NO ABSTRACTPMID:38563192 | DOI:10.1080/03009742.2024.2330248 (Source: Scandinavian Journal of Rheumatology)
Source: Scandinavian Journal of Rheumatology - April 2, 2024 Category: Rheumatology Authors: X Wang W Feng Source Type: research
Comparing the safety and efficacy of nintedanib starting dose in patients with connective tissue disease-associated interstitial lung diseases
CONCLUSION: There was no evidence for a difference between the two groups in terms of discontinuation rates, efficacy, and safety. To provide further evidence, future studies using more precise dose-escalation protocols are warranted.PMID:38563202 | DOI:10.1080/03009742.2024.2327159 (Source: Scandinavian Journal of Rheumatology)
Source: Scandinavian Journal of Rheumatology - April 2, 2024 Category: Rheumatology Authors: M Ayano K Tsubouchi K Suzuki Y Kimoto Y Arinobu K Akashi T Horiuchi I Okamoto H Niiro Source Type: research
Van Neck-Odelberg disease in an elderly patient
Scand J Rheumatol. 2024 Apr 2:1-2. doi: 10.1080/03009742.2024.2330248. Online ahead of print.NO ABSTRACTPMID:38563192 | DOI:10.1080/03009742.2024.2330248 (Source: Scandinavian Journal of Rheumatology)
Source: Scandinavian Journal of Rheumatology - April 2, 2024 Category: Rheumatology Authors: X Wang W Feng Source Type: research
Comparing the safety and efficacy of nintedanib starting dose in patients with connective tissue disease-associated interstitial lung diseases
CONCLUSION: There was no evidence for a difference between the two groups in terms of discontinuation rates, efficacy, and safety. To provide further evidence, future studies using more precise dose-escalation protocols are warranted.PMID:38563202 | DOI:10.1080/03009742.2024.2327159 (Source: Scandinavian Journal of Rheumatology)
Source: Scandinavian Journal of Rheumatology - April 2, 2024 Category: Rheumatology Authors: M Ayano K Tsubouchi K Suzuki Y Kimoto Y Arinobu K Akashi T Horiuchi I Okamoto H Niiro Source Type: research
Van Neck-Odelberg disease in an elderly patient
Scand J Rheumatol. 2024 Apr 2:1-2. doi: 10.1080/03009742.2024.2330248. Online ahead of print.NO ABSTRACTPMID:38563192 | DOI:10.1080/03009742.2024.2330248 (Source: Scandinavian Journal of Rheumatology)
Source: Scandinavian Journal of Rheumatology - April 2, 2024 Category: Rheumatology Authors: X Wang W Feng Source Type: research
Comparing the safety and efficacy of nintedanib starting dose in patients with connective tissue disease-associated interstitial lung diseases
CONCLUSION: There was no evidence for a difference between the two groups in terms of discontinuation rates, efficacy, and safety. To provide further evidence, future studies using more precise dose-escalation protocols are warranted.PMID:38563202 | DOI:10.1080/03009742.2024.2327159 (Source: Scandinavian Journal of Rheumatology)
Source: Scandinavian Journal of Rheumatology - April 2, 2024 Category: Rheumatology Authors: M Ayano K Tsubouchi K Suzuki Y Kimoto Y Arinobu K Akashi T Horiuchi I Okamoto H Niiro Source Type: research
Van Neck-Odelberg disease in an elderly patient
Scand J Rheumatol. 2024 Apr 2:1-2. doi: 10.1080/03009742.2024.2330248. Online ahead of print.NO ABSTRACTPMID:38563192 | DOI:10.1080/03009742.2024.2330248 (Source: Scandinavian Journal of Rheumatology)
Source: Scandinavian Journal of Rheumatology - April 2, 2024 Category: Rheumatology Authors: X Wang W Feng Source Type: research
Comparing the safety and efficacy of nintedanib starting dose in patients with connective tissue disease-associated interstitial lung diseases
CONCLUSION: There was no evidence for a difference between the two groups in terms of discontinuation rates, efficacy, and safety. To provide further evidence, future studies using more precise dose-escalation protocols are warranted.PMID:38563202 | DOI:10.1080/03009742.2024.2327159 (Source: Scandinavian Journal of Rheumatology)
Source: Scandinavian Journal of Rheumatology - April 2, 2024 Category: Rheumatology Authors: M Ayano K Tsubouchi K Suzuki Y Kimoto Y Arinobu K Akashi T Horiuchi I Okamoto H Niiro Source Type: research
Van Neck-Odelberg disease in an elderly patient
Scand J Rheumatol. 2024 Apr 2:1-2. doi: 10.1080/03009742.2024.2330248. Online ahead of print.NO ABSTRACTPMID:38563192 | DOI:10.1080/03009742.2024.2330248 (Source: Scandinavian Journal of Rheumatology)
Source: Scandinavian Journal of Rheumatology - April 2, 2024 Category: Rheumatology Authors: X Wang W Feng Source Type: research
Comparing the safety and efficacy of nintedanib starting dose in patients with connective tissue disease-associated interstitial lung diseases
CONCLUSION: There was no evidence for a difference between the two groups in terms of discontinuation rates, efficacy, and safety. To provide further evidence, future studies using more precise dose-escalation protocols are warranted.PMID:38563202 | DOI:10.1080/03009742.2024.2327159 (Source: Scandinavian Journal of Rheumatology)
Source: Scandinavian Journal of Rheumatology - April 2, 2024 Category: Rheumatology Authors: M Ayano K Tsubouchi K Suzuki Y Kimoto Y Arinobu K Akashi T Horiuchi I Okamoto H Niiro Source Type: research
